Skip to main content

Solventum Corporation(SOLV-N)
NYSE

Today's Change
Real-Time Last Update Last Sale Cboe BZX Real-Time
Day Low68.99
Day High70.44
Open:70.00
Price movement based on the high, low and last over the given period.
Previous Close
52-Week High/Low
Volume
Average Volume
Price/Earnings (TTM)
Forward Annual Dividend & Yield
Market Capitalization, $M
5-Day Change
Realtime quote and/or trade prices are not sourced from all markets.

TOP STORIES: Solventum Corporation

Select a category then submit the form to load news
Tipranks
Analysts Offer Insights on Healthcare Companies: Veeva Systems (VEEV), BillionToOne, Inc. Class A (BLLN) and Solventum Corporation (SOLV)
Tipranks
UBS Reaffirms Their Hold Rating on Solventum Corporation (SOLV)
Tipranks
Solventum Earnings Call Balances Growth With Headwinds
Tipranks
Solventum’s High-Stakes Restructuring: Profitability Ambitions Face Significant Execution Risks
Tipranks
Solventum Corporation (SOLV) Receives a Buy from Stifel Nicolaus
Tipranks
BTIG Reaffirms Their Buy Rating on Solventum Corporation (SOLV)
Tipranks
Analysts Offer Insights on Healthcare Companies: DENTSPLY SIRONA (XRAY), Solventum Corporation (SOLV) and Privia Health Group (PRVA)
StockStory
Clover Health, Alignment Healthcare, Solventum, ANI Pharmaceuticals, and Guardant Health Shares Plummet, What You Need To Know
CLOV
Zacks Investment Research
Solventum Stock Down Despite Q4 Earnings & Revenues Beat, Margins Down
Solventum Stock Down Despite Q4 Earnings & Revenues Beat, Margins Down
Motley Fool
Solventum (SOLV) Q4 2025 Earnings Call Transcript
StockStory
Solventum’s (NYSE:SOLV) Q4 CY2025 Sales Top Estimates
SOLV
Tipranks
Solventum Corporation (SOLV) Receives a Buy from Piper Sandler
StockStory
What To Expect From Solventum’s (SOLV) Q4 Earnings
SOLV
Tipranks
BTIG Remains a Buy on Solventum Corporation (SOLV)
StockStory
1 S&P 500 Stock with Competitive Advantages and 2 We Turn Down
VMC
StockStory
3 Profitable Stocks Walking a Fine Line
ITW
StockStory
3 Value Stocks We Keep Off Our Radar
RAMP
Tipranks
BTIG Remains a Buy on Solventum Corporation (SOLV)
Tipranks
Mizuho Securities upgrades Solventum Corporation (SOLV) to a Buy
Tipranks
Analysts Offer Insights on Healthcare Companies: Solventum Corporation (SOLV) and Praxis Precision Medicines (PRAX)
Tipranks
Solventum Corporation (SOLV) Receives a Hold from Wells Fargo
StockStory
3 Reasons SOLV is Risky and 1 Stock to Buy Instead
SOLV
Tipranks
Solventum Corporation (SOLV) Gets a Buy from Stifel Nicolaus
Tipranks
Analysts Offer Insights on Healthcare Companies: Solventum Corporation (SOLV), Avalo Therapeutics (AVTX) and Lifestance Health Group (LFST)
Tipranks
Solventum Corporation Reflects on Transformative Year
Tipranks
Argus Research Remains a Buy on Solventum Corporation (SOLV)
Tipranks
Wells Fargo Sticks to Their Hold Rating for Solventum Corporation (SOLV)
StockStory
3 Value Stocks with Open Questions
CAG
StockStory
1 Mid-Cap Stock on Our Buy List and 2 We Question
NXT
Zacks Investment Research
BD Stock Up Post Tie-Up to Expand Hazardous Drug Contamination Testing
BD Stock Up Post Tie-Up to Expand Hazardous Drug Contamination Testing
Motley Fool
These Are the 3 Hottest Stocks in the S&P 500 Heading Into the New Year. Should You Invest in Them?
StockStory
1 Unpopular Stock That Should Get More Attention and 2 We Ignore
CL

Profile

Solventum is an independent healthcare company. Its business segment includes Medical Surgical, Dental Solutions, Health Information Systems and Purification and Filtration. Solventum is based in ST. PAUL, Minn.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).

Copyright © 2026 Morningstar. All Rights Reserved. The information contained herein: (1) is proprietary to Morningstar and/or its content providers; (2) may not be copied or distributed; and (3) is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information. Past performance is no guarantee of future results.